Trial · NCT02972918
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The effects of Levosimendan on left ventricular function. | Baseline and every 24 hours postoperative, 48 h postoperative, and 7 days and after 30 days postoperative. | Changes of left ventricular function as assessed transthoracic. |
| Primary | Change in cardiac index | 48 hours after start of iv infusion | Measured through arterial pulse wave analysis. A baseline measurement is done before infusion is started |
| Secondary | Changes in transport and tissue perfusion of oxygen | 1 to 2 day postoperative | measured by arterial and venous blood gases |
| Secondary | Changes in renal function | 1 to 7 days postoperative | Proportion of subjects who develop AKIN stage 1 (increase \> 0.3 mg/dl or \> 25% in serum creatinine from previous visit) |
| Secondary | Changes in NT-proBNP and troponin I | 24 hours postoperative, 48 h postoperative, 72 h postoperative, and 168 h postoperative | Plasma NT-proBNP levels were measured |
| Secondary | Number of patients with adverse. | 30 days postoperative | Development of arrhythmias |
| Secondary | Number of patients with adverse. | 30 days postoperative | Occurence of nausea/vomiting |
| Secondary | Number of patients with adverse event. | 30 days postoperative | Occurence of headache |
| Secondary | Use of high inotropes (dopamine, Norepinephrine) | after 12 hours, after 48 hours and every 24 hours if still in the PO-Unit | during postoperative unit stay. |
| Secondary | morbidity | 3 months | All cause |
| Secondary | Major adverse cardiovascular events | 1st-30th postoperative day | Perioperative heart failure infarction, stroke |
| Secondary | Time on mechanical ventilation | 1st-30th postoperative day | Perioperative heart failure infarction, stroke |
| Secondary | mortality | measured at 3 months | All cause |
| Secondary | Perioperative mortality | 7 days postoperative | All cause |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02972918/registered